Correlation Between Takeda Pharmaceutical and CME

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and CME at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and CME into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical and CME Group, you can compare the effects of market volatilities on Takeda Pharmaceutical and CME and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of CME. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and CME.

Diversification Opportunities for Takeda Pharmaceutical and CME

-0.42

Correlation Coefficient

Takeda Pharmaceutical  CME

Very good diversification

The 3 months correlation between Takeda and CME is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and CME Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CME Group and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with CME. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CME Group has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and CME go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and CME

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to under-perform the CME. In addition to that, Takeda Pharmaceutical is 1.01 times more volatile than CME Group. It trades about -0.04 of its total potential returns per unit of risk. CME Group is currently generating about 0.2 per unit of volatility. If you would invest  19,504  in CME Group on September 27, 2024 and sell it today you would earn a total of  3,371  from holding CME Group or generate 17.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Takeda Pharmaceutical  vs.  CME Group

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

CME Group

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CME Group are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, CME reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and CME

The main advantage of trading using opposite Takeda Pharmaceutical and CME positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, CME can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will offset losses from the drop in CME's long position.

The idea behind Takeda Pharmaceutical and CME Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .